Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Jan;36(1):41–44.

Cystic fibrosis carrier frequencies in populations of African origin

C Padoa 1, A Goldman 1, T Jenkins 1, M Ramsay 1
PMCID: PMC1762947  PMID: 9950364

Abstract

Cystic fibrosis (CF) is a common autosomal recessive disorder in populations of European descent. However, very little is known about CF in populations of African origin among whom it has been believed to be extremely rare. The aim of this study was to determine if this is the case or whether it is under-reported. A CFTR mutation, 3120+1G→A, which was first reported in three African-American CF patients, has been shown to account for 9-14% of African-American CF chromosomes. It has also been found in 4/6 CF chromosomes in South African blacks and one CF chromosome of Cameroonian origin. In order to determine the carrier frequency of the 3120+1G→A mutation in Africa, 1360 unrelated, healthy subjects were screened. Nine carriers were identified. In addition, two out of five black CF patients with positive sweat tests were found to be heterozygous for the 3120+1G→A mutation and two out of another four black patients with symptoms suggestive of CF, but unconfirmed by sweat tests, were heterozygous for the D1270N mutation. A further three CFTR mutations, A559T, S1255X, and 444delA, which had been found in African-American CF patients, were not identified in the patients or in over 373 healthy subjects tested. The 3120+1G→A mutation has a carrier frequency of 1 in 91 (8/728) in South African blacks with a 95% confidence interval of 1 in 46 to 1 in 197. Since this mutation accounts for between 15% and 65% of CF chromosomes in South African blacks, a corrected CF carrier frequency would be between 1 in 14 and 1 in 59. Hence, the incidence of CF would be predicted to be between 1 in 784 and 1 in 13 924 births in this population. There are several possible reasons why these people are not being detected. Some of these are misdiagnosis as chronic pulmonary infection, malnutrition, tuberculosis, infantile diarrhoea, failure to thrive, or a high infant mortality rate.


Keywords: CF; African blacks; 3120+1G→A mutation; heterozygote frequencies

Full Text

The Full Text of this article is available as a PDF (76.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anguiano A., Oates R. D., Amos J. A., Dean M., Gerrard B., Stewart C., Maher T. A., White M. B., Milunsky A. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. JAMA. 1992 Apr 1;267(13):1794–1797. [PubMed] [Google Scholar]
  2. Beutler E. G6PD deficiency. Blood. 1994 Dec 1;84(11):3613–3636. [PubMed] [Google Scholar]
  3. Carles S., Desgeorges M., Goldman A., Thiart R., Guittard C., Kitazos C. A., de Ravel T. J., Westwood A. T., Claustres M., Ramsay M. First report of CFTR mutations in black cystic fibrosis patients of southern African origin. J Med Genet. 1996 Sep;33(9):802–804. doi: 10.1136/jmg.33.9.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cutting G. R., Antonarakis S. E., Buetow K. H., Kasch L. M., Rosenstein B. J., Kazazian H. H., Jr Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene. Am J Hum Genet. 1989 Mar;44(3):307–318. [PMC free article] [PubMed] [Google Scholar]
  5. Cutting G. R., Kasch L. M., Rosenstein B. J., Tsui L. C., Kazazian H. H., Jr, Antonarakis S. E. Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med. 1990 Dec 13;323(24):1685–1689. doi: 10.1056/NEJM199012133232407. [DOI] [PubMed] [Google Scholar]
  6. Cutting G. R., Kasch L. M., Rosenstein B. J., Zielenski J., Tsui L. C., Antonarakis S. E., Kazazian H. H., Jr A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 1990 Jul 26;346(6282):366–369. doi: 10.1038/346366a0. [DOI] [PubMed] [Google Scholar]
  7. Dörk T., El-Harith E. H., Stuhrmann M., Macek M., Jr, Egan M., Cutting G. R., Tzetis M., Kanavakis E., Carles S., Claustres M. Evidence for a common ethnic origin of cystic fibrosis mutation 3120+1G-->A in diverse populations. Am J Hum Genet. 1998 Aug;63(2):656–662. doi: 10.1086/301950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GLASS B., LI C. C. The dynamics of racial intermixture; an analysis based on the American Negro. Am J Hum Genet. 1953 Mar;5(1):1–20. [PMC free article] [PubMed] [Google Scholar]
  9. GROVE S. S. Fibrocystic disease of the pancreas in the Bantu. S Afr J Lab Clin Med. 1959 Jun;5(2):113–119. [PubMed] [Google Scholar]
  10. Hamosh A., FitzSimmons S. C., Macek M., Jr, Knowles M. R., Rosenstein B. J., Cutting G. R. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998 Feb;132(2):255–259. doi: 10.1016/s0022-3476(98)70441-x. [DOI] [PubMed] [Google Scholar]
  11. Levin S. E., Blumberg H., Zamit R., Schmaman A., Wagstaff L. Mucoviscidosis (cystic fibrosis of the pancreas) in Bantu twin neonates. S Afr Med J. 1967 May 13;41(19):482–485. [PubMed] [Google Scholar]
  12. Macek M., Jr, Mackova A., Hamosh A., Hilman B. C., Selden R. F., Lucotte G., Friedman K. J., Knowles M. R., Rosenstein B. J., Cutting G. R. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet. 1997 May;60(5):1122–1127. [PMC free article] [PubMed] [Google Scholar]
  13. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Morton J. E., Bundey S., Webb T. P., MacDonald F., Rindl P. M., Bullock S. Fragile X syndrome is less common than previously estimated. J Med Genet. 1997 Jan;34(1):1–5. doi: 10.1136/jmg.34.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nagel R. L., Fleming A. F. Genetic epidemiology of the beta s gene. Baillieres Clin Haematol. 1992 Apr;5(2):331–365. doi: 10.1016/s0950-3536(11)80023-5. [DOI] [PubMed] [Google Scholar]
  16. Tzetis M., Kanavakis E., Antoniadi T., Doudounakis S., Adam G., Kattamis C. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novel mutations. Hum Genet. 1997 Jan;99(1):121–125. doi: 10.1007/s004390050324. [DOI] [PubMed] [Google Scholar]
  17. White M. B., Krueger L. J., Holsclaw D. S., Jr, Gerrard B. C., Stewart C., Quittell L., Dolganov G., Baranov V., Ivaschenko T., Kapronov N. I. Detection of three rare frameshift mutations in the cystic fibrosis gene in an African-American (CF444delA), an Italian (CF2522insC), and a Soviet (CF3821delT). Genomics. 1991 May;10(1):266–269. doi: 10.1016/0888-7543(91)90510-l. [DOI] [PubMed] [Google Scholar]
  18. Zielenski J., Rozmahel R., Bozon D., Kerem B., Grzelczak Z., Riordan J. R., Rommens J., Tsui L. C. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991 May;10(1):214–228. doi: 10.1016/0888-7543(91)90503-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES